HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keith V Nance Selected Research

Neoplasms (Cancer)

3/2010Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keith V Nance Research Topics

Disease

1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2013
1Lung Neoplasms (Lung Cancer)
01/2013
1Neoplasms (Cancer)
03/2010
1Renal Cell Carcinoma (Grawitz Tumor)
03/2010

Drug/Important Bio-Agent (IBA)

1Pemetrexed (MTA)FDA Link
01/2013
1ErbB Receptors (EGF Receptor)IBA
01/2013
1Eosine Yellowish-(YS) (Eosin)IBA
01/2013
1Hematoxylin (Haematoxylon)IBA
01/2013
1Bevacizumab (Avastin)FDA Link
01/2013
1Tyrosine Kinase InhibitorsIBA
03/2010
1Sorafenib (BAY 43-9006)FDA Link
03/2010

Therapy/Procedure

2Therapeutics
01/2013 - 03/2010
1Preoperative Period
03/2010
1Nephrectomy
03/2010